1. Share Prices

  2. Alliance Pharma PLC (APH)

36.75p+0.15 (+0.41%)18 Apr 2024, 07:15
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Alliance Pharma PLC Fundamentals

Company NameAlliance Pharma PLCLast Updated2024-04-18
IndustryDrug Manufacturers - Specialty & GenericSectorHealthcare
Shares in Issue540.400 mMarket Cap£198.60 m
PE Ratio285.71Dividend per Share£0.02
Dividend Yield3.23Dividend Cover0.10
EPS£0.00EPS Growth (%)0
PEG0DPS Growth (%)0.0507
Debt Ratio0.2422Debt Equity Ratio0.4467
Asset Equity Ratio1.8549Cash Equity Ratio0.0943
Quick Ratio1.3331Current Ratio1.93
Price To Book Value0.7171ROCE0

Alliance Pharma PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Prelim2023-06-222023-07-18GBP0.0118
Interim2022-12-222023-01-19GBP0.0059
Prelim2022-06-092022-07-07GBP0.0113
Interim2021-12-162022-01-07GBP0.0056
Prelim2021-06-102021-07-08GBP0.0107

Alliance Pharma PLC Company Financials

Assets20222021
Tangible Assets£5.58 m£4.83 m
Intangible Assets£421.63 m£413.74 m
Investments00
Total Fixed Assets£431.93 m£422.47 m
Stocks£24.29 m£21.07 m
Debtors£48.23 m£30.82 m
Cash & Equivalents£31.71 m£29.06 m
Other Assets00
Total Assets£537.41 m£503.49 m
Liabilities20222021
Creditors within 1 year£47.02 m£40.58 m
Creditors after 1 year£202.73 m£180.43 m
Other Liabilities00
Total Liabilities£249.75 m£221.00 m
Net assets£287.66 m£282.49 m
Equity20222021
Called up share capital£5.40 m£5.38 m
Share Premium£151.65 m£151.33 m
Profit / Loss£5.21 m£18.16 m
Other Equity£287.66 m£282.49 m
Preference & Minorities00
Total Capital Employed£287.66 m£282.49 m
Ratios20222021
Debt Ratio£0.32£0.30
Debt-to-Equity£0.48£0.42
Assets / Equity1.85491.8549
Cash / Equity0.09430.0943
EPS£-0.00£0.01
Cash Flow20222021
Cash from operating activities£20.97 m£38.66 m
Cashflow before financing£20.10 m£4.32 m
Increase in Cash£3.07 m-£284,000.00
Income20222021
Turnover£167.42 m£163.21 m
Cost of sales£65.73 m£53.76 m
Gross Profit£101.68 m£109.45 m
Operating Profit£10.57 m£21.57 m
Pre-Tax profit£5.21 m£18.16 m

Alliance Pharma PLC Company Background

SectorHealthcare
ActivitiesAlliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).
Latest Interim Date26 Sep 2023
Latest Fiscal Year End Date23 Apr 2024

Alliance Pharma PLC Directors

AppointedNamePosition
2014-12-30Mr. Paul RansonNon-Executive Director
2018-03-01Mr. Andrew Leonard SmithNon-Executive Director,Chairman
2014-05-23Mr. Michael Richard Brock GatenbyNon-Executive Director,Chairman
2015-05-29Mr. Richard David WrightExecutive Director,Finance Director
2019-07-01Mr. John DawsonNon-Executive Director
2021-04-15Mr. Nigel Richard Clifford Non-Executive Director
2019-04-25Mr. Anthony Richard BooleyExecutive Director,Sales and Marketing Director
2019-04-16Mr. Thomas Theodore CasdagliNon-Executive Director
2023-10-16Mr. Peter Jonathan ButterfieldExecutive Director,Chief Executive Officer
2006-12-31Ms. Stella Anne Dawson BSc,MScExecutive Director,Acquisition Integration Director
2006-12-31Ms. Madeleine Elizabeth Scott ACCA,ACISExecutive Director,Finance Director and Company Secretary
2011-08-09Dr. Mark John Tomlinson MB,BCh,MRCGPExecutive Director,Medical Director
2023-03-23Mr. David John CookNon-Executive Director,Chairman
2023-10-16Mr. Andrew Timothy FranklinExecutive Director,Finance Director
2023-07-19Mr. Richard Crispin Morgan JonesNon-Executive Director,Senior Independent Director
2024-02-19Ms. Joanna Susan Le CouilliardNon-Executive Director,Chairman
2023-10-05Mr. Jeyan HeperExecutive Director,Chief Operating Officer

Alliance Pharma PLC Contact Details

Company NameAlliance Pharma PLC
AddressBath Road, Avonbridge House, Chippenham, SN15 2BB
Telephone+44 1249466966
Websitehttps://www.alliancepharmaceuticals.com

Alliance Pharma PLC Advisors

AuditorKPMG
Phone+44 01179054000
Fax+44 01179054001
BankSilicon Valley Bank
BankRoyal Bank of Scotland PLC
Nominated AdviserNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
StockbrokerNumis Securities Limited
Phone+44 2072601000
BankLloyds Bank PLC
Financial PR AdviserBuchanan
Phone+44 2074665000
Fax+44 2074665001
SolicitorFasken Martineau LLP
Phone(020) 7917 8500
Fax(020) 7917 8555
AuditorGrant Thornton UK LLP
Phone+44 2073835100
Fax+44 2073834715

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
18 Apr 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Hipgnosis Songs Fund Limited92.0030.50
Wizz Air Holdings PLC2,118.006.59
International Consolidated Airlines Group S.A.169.805.66
Wood Group (John) PLC151.005.45
Prudential PLC722.804.42
Dr. Martens PLC69.854.25

Fallers

CompanyPrice% Chg
Rentokil Initial PLC412.90-7.61
Dunelm Group PLC995.50-7.31
Future PLC631.50-4.39
Watches Of Switzerland Group PLC336.00-3.89
Vesuvius PLC457.50-3.68
Quilter PLC99.00-3.41
Risers/fallers data from previous trading day. Today's data available from 8:15am.